Sponsor or institution

Clinical trials and research at Beijing 302 Hospital

• 11Clinical trials
• 1Country

Newest trials

All recruiting trials (11)

• Targeted Therapies for Immunological Non-Responders in HIV

  This study tests adding rilpivirine to a stable ART regimen in people with HIV whose CD4 counts stay low despite long-term viral suppression.

  Recruiting at 5 sites Phase 2 Beijing 302 Hospital · Beijing, Beijing Municipality and 4 other locations · NCT07637877

• VA-CIG as initial intensive therapy for fit adults with acute myeloid leukemia

  This study will test whether combining venetoclax with azacitidine, idarubicin, low-dose cytarabine, and G-CSF works as induction treatment for adults aged 18–70 with previously untreated, fit AML.

  Recruiting Phase 2 Beijing 302 Hospital · Beijing · NCT07514832

• Chemotherapy plus HLA-mismatched G-CSF mobilized peripheral blood cells as a bridge to allogeneic stem cell transplant for relapsed or refractory leukemia

  This trial will test whether adding an HLA-mismatched G-CSF mobilized peripheral blood mononuclear cell infusion to chemotherapy can safely help people with relapsed or refractory leukemia reach an allogeneic stem cell transplant.

  Recruiting Phase 1 Beijing 302 Hospital · Beijing · NCT07297173

• Venetoclax-based therapy plus microtransplant for intermediate- or higher-risk MDS

  This trial tests whether adding HLA-mismatched donor G-CSF–mobilized blood-cell infusions to venetoclax combined with a hypomethylating agent can help adults with intermediate- or higher-risk myelodysplastic syndromes who are not candidates for stem-cell transplant.

  Recruiting Phase 2 Beijing 302 Hospital · Beijing · NCT07238686

• ERCG (clip-and-loop endoscopic gastric reduction) versus optimized lifestyle for weight loss

  This trial will test whether ERCG, a sutureless endoscopic clip-and-loop procedure that reduces stomach volume, helps Chinese adults with BMI 24.0–37.4 kg/m² lose more weight than an optimized lifestyle program.

  Recruiting Beijing 302 Hospital · Beijing, Beijing Municipality and 1 other locations · NCT07237750

• Venetoclax-based therapy combined with donor microtransplant for newly diagnosed AML

  This will test whether giving HLA-mismatched donor G-CSF mobilized blood cells alongside venetoclax-containing therapy helps adults newly diagnosed with AML live longer.

  Recruiting Phase 2 Beijing 302 Hospital · Beijing · NCT07078591

• Evaluating a new chemotherapy regimen for relapsed or refractory AML

  This study is testing a new combination of chemotherapy drugs to see if it can help people with acute myeloid leukemia that hasn't responded to other treatments.

  Recruiting Phase 2 Beijing 302 Hospital · Beijing · NCT06741722

• Combining PD-1 inhibitor with venetoclax for treating tough cases of leukemia and myelodysplastic syndromes

  This study is testing a new treatment that combines three drugs to see if it can help people with tough cases of leukemia and myelodysplastic syndromes who haven't responded to other treatments.

  Recruiting Phase 2 Beijing 302 Hospital · Beijing, Beijing Municipality · NCT06536959

• Combination treatment for HER2-negative breast cancer brain metastasis

  This study is testing a new combination treatment for patients with HER2-negative breast cancer that has spread to the brain to see if it can help shrink tumors and improve survival.

  Recruiting Phase 2 Beijing 302 Hospital · Beijing, Beijing Municipality · NCT06418594

• Transplanting stem cells from umbilical cords to treat liver failure

  This study is testing if transplanting stem cells from umbilical cords can help people with severe liver failure feel better and improve their health.

  Recruiting Phase 1/2 Beijing 302 Hospital · Beijing, Beijing Municipality · NCT05985863

• Using stem cells from umbilical cords to treat severe liver disease

  This study is testing whether stem cells from umbilical cords can help people with severe liver disease feel better and avoid the need for a liver transplant.

  Recruiting at 3 sites Phase 2 Beijing 302 Hospital · Lanzhou, Gansu and 6 other locations · NCT05224960

Quick answers

How many clinical trials run by Beijing 302 Hospital are recruiting right now?

11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 8, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →